Table of Contents Table of Contents
Previous Page  143 / 398 Next Page
Information
Show Menu
Previous Page 143 / 398 Next Page
Page Background

138

Development of a dual-modally traceable nanoplatform for

cancer theranostics using natural circulating microparticles

in oral cancer patients

Z.L. Yu

∗

, W. Zhang, Y.F. Zhao

Department of Oral and Maxillofacial Surgery, School and

Hospital of Stomatology, Wuhan University, Wuhan, China

Background:

Circulating microparticles (CMPs), which are

nano-sized (100–1000 nm) membrane vesicles shed into circula-

tion by various cell types, have been recently recognised as natural

conveyors of molecular information and exhibit great potential to

serve as therapeutic platforms.

Objectives:

The present study aims to transform the CMPs into

multifunctional therapeutic nanovectors.

Methods:

CMPs, which were freshly purified from the periph-

eral blood of oral squamous cell carcinoma (OSCC) patients,

were embeddedwith ultrasmall near infrared-fluorescent magnetic

quantum dots (Ag2Se@Mn QDs) via electroporation. The tissue

distribution and natural tumour-targeting behaviour of CMPs were

evaluated in living mice with

in vivo

magnetic resonance imaging

(MRI) system and 7.0 T small animal MRI scanner. To develop

a dual-modally traceable nanoplatform for cancer theranostics,

siRNA and Ag2Se@Mn QDs were simultaneously loaded into

CMPs via electroporation.

Findings:

CMPs were efficiently labeled with Ag2Se QDs

through electroporation with favourable biocompatibility. Due to

the favourable biocompatibility and superior dual-mode traceabil-

ity of Ag2Se@Mn QD-labeled CMPs, we investigated the

in vivo

biodistribution patterns of CMPs and revealed the excellent natural

tumour-targeting activity of CMPs in living mice. Importantly, the

siRNA/Ag2Se QDs-loaded CMPs exhibited excellent therapeutic

effects in an oral cancer-bearing mouse model.

Conclusions:

This study not only realised the first efficient

labelling and

in vivo

dual-mode tracking of CMPs that were

directly isolated from human body fluids but also transformed

these naturally occurring MPs into multifunctional nanovectors,

opening new avenues for the development of real natural thera-

nostic nanoplatforms.

http://dx.doi.org/10.1016/j.ijom.2017.02.478

CXCL12 via recruiting regulatory CD4(+) T cells promote

tumour progression in tumour microenvironment

B. Zhang

∗

, C. Li, L. Li

West China Hospital of Stomatology (Sichuan University),

Chengdu, China

Background:

Signals mediated by CXCL12 (SDF1) and its recep-

tor CXCR4 are centrally involved in cancer progression, both

directly by activating cancer cells and indirectly by inducing

angiogenesis plus recruiting regulatory T cells. FoxP3+ T cells, a

marker for regulatory CD4(+) T cells (Tregs), populate tumours

and regulate antitumour immunity.

Objective:

To explore the antitumour immunity role of SDF1 in

tumour microenvironment, we stained and counted the number of

Tregs in 72 oral squamous cell carcinoma (OSCC) patients via

immunohistochemistry staining of FoxP3+.

Findings and Conclusions:

The results indicated that a positive

correlation between CXCL12 expression levels and Tregs number.

In this series of 72 OSCC patients, the SDF-1 expression level cor-

related significantly with overall survival. Our findings elucidate

a central role for SDF1 recruiting Tregs in tumour microenvi-

ronment promoting tumour progression. The prognostic value of

SDF1 was confirmed by a multivariate analysis.

http://dx.doi.org/10.1016/j.ijom.2017.02.479

Overexpression of stathmin 1 leads to docetaxel based

induction chemotherapy resistance via mutant p53 in oral

squamous cell carcinoma

L.P. Zhong

∗

, H.L. Ma, S.F. Jin, Y.Y. Tu, L. Jiang, Z.Y. Zhang

Department of Oral and Maxillofacial-Head and Neck

Oncology, Ninth People’s Hospital, Shanghai Jiao Tong

University School of Medicine, Shanghai, China

Background:

A phase 3 trial (NCT01542931) demonstrated fail-

ure to improve survival when docetaxel, cisplatin, 5-fluorouracil

(TPF) induction chemotherapy was added to standard therapy

compared to standard therapy alone in patients with locally

advanced oral squamous cell carcinoma (OSCC).

Objectives:

To investigate the predictive value of stathmin expres-

sion and its role in tumourigenesis and chemoresistance as well

as its transcriptional regulation by mutant p53 in OSCC.

Methods:

Expression of stathmin was evaluated by immunohisto-

chemistry in pretreatment biopsies from 256 OSCC patients in the

phase 3 trial. Tumourigenicity and chemoresistance regulated by

stathmin was investigated using

in vitro

and

in vivo

OSCCmodels.

Regulation of mutant p53 on stathmin was detected by ChIP and

dual-luciferase reporter assays.

Findings and Conclusion:

OSCC patients with low stath-

min expression benefited from TPF induction chemother-

apy, which was associated with increased overall survival

(

P

= 0.028), disease-free survival (

P

= 0.010), locoregional

recurrence-free survival (

P

= 0.010), and distant metastasis-free

survival (

P

= 0.027). Overexpression of stathmin was identified

and confirmed in OSCC tissues and lines. Downregulation of

stathmin expression in OSCC lines significantly inhibited cell

proliferation, colony formation, migration and tumourigenesis,

and enhanced sensitivity to docetaxel and cisplatin

in vitro

and

in vivo

. Mutant p53 (R175H, G245C, and R282W) bound to

the stathmin promoter and transcriptionally regulated stathmin

expression. These results suggest that low stathmin expression

is a predictive biomarker, identifying those patients with locally

advanced OSCC who may benefit from TPF induction chemother-

apy. Overexpression of stathmin promotes tumour progression and

chemoresistance to docetaxel and cisplatin, and it is transcription-

ally activated by mutant p53 in OSCC.

http://dx.doi.org/10.1016/j.ijom.2017.02.480